Rocket Lab USA, Inc. (RKLB) has successfully completed a major capital raise while securing new launch contracts, fueling analyst optimism for the stock. The company finalized its at-the-market (ATM) equity offering program, selling approximately 6.7 million shares and raising roughly $474 million in gross proceeds. This program, initiated with a March 17, 2026 prospectus supplement to sell up to $1 billion in stock, is now complete.
The capital structure also includes collared forward transactions involving around 7.5 million shares, with minimum expected proceeds of about $474 million and a maximum of roughly $642 million. These transactions have maturity dates set for April 2028, though early settlement remains an option. Rocket Lab stated the net proceeds will be used to fund future growth, including potential acquisitions, and for general corporate and working capital purposes.
Concurrently, Rocket Lab announced a new multi-launch agreement with the Institute for Q-shu Pioneers of Space (iQPS) for three additional Electron rocket missions, scheduled to begin no earlier than 2028 from Launch Complex 1 in New Zealand. This deal brings the total mission count between the two companies to 15, with seven already completed since 2023. Notably, this marks iQPS's second multi-launch order with Rocket Lab in just six months, a sign of strong operational reliability. The missions will deploy QPS-SAR satellites using Rocket Lab's Motorized Lightband separation system.
Analysts have responded positively to these developments. Citizens analyst Trevor Walsh upgraded RKLB from Hold to Buy, maintaining a price target of $85, which implies roughly 25% upside. Walsh cited current price levels as a strong entry point and highlighted Rocket Lab's push into defense and space services as a path to higher margins. Roth MKM analyst Sujeeva De Silva reaffirmed a Buy rating with a $90 target, pointing to the company's growing backlog and expansion into satellite components as evidence it is "successfully diversifying into Space Systems."
The consensus on TipRanks is a Moderate Buy rating, based on 10 Buy and 5 Hold ratings over the last three months. The average analyst price target is $86.77, suggesting about 25.6% to 30% upside from current trading levels. Analysts also flag the anticipated development of the Neutron rocket as a key future catalyst. The 43-meter, partially reusable vehicle, with key components ready for final assembly, is expected to launch in late 2026 or early 2027 and could address a larger market than the Electron rocket.
In other corporate developments, Rocket Lab received German regulatory approval for its planned ~$75 million acquisition of Mynaric, expected to close in April. The company reported revenue of $601.8 million over the last twelve months, representing 38% year-over-year growth.
